Cefazolin

Hazard statements (CLP)

H317, H334

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture Respiratory sensitisation, H334: May cause allergy or asthma Category 1) symptoms or breathing difficulties if inhaled Skin sensitisation, (Category 1) H317: May cause an allergic skin reaction

Signal word

Danger

Hazard statements

H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Precautionary statements

P261 Avoid breathing dust. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P284 Wear respiratory protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.

Supplemental label elements

none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Respiratory sensitisation, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Skin sensitisation, (Category 1) H317: May cause an allergic skin reaction.